Filing Details

Accession Number:
0001127602-15-031279
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-13 12:22:30
Reporting Period:
2015-11-12
Filing Date:
2015-11-13
Accepted Time:
2015-11-13 12:22:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
799729 Parexel International Corp PRXL Services-Commercial Physical & Biological Research (8731) 042776269
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1552687 Gadi Saarony C/O Parexel International
195 West Street
Waltham MA 02451
Senior Vice President, Crs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-12 6,200 $20.26 18,117 No 4 M Direct
Common Stock Acquisiton 2015-11-12 2,325 $30.64 20,442 No 4 M Direct
Common Stock Acquisiton 2015-11-12 3,900 $48.69 24,342 No 4 M Direct
Common Stock Disposition 2015-11-12 12,425 $67.01 11,917 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-11-12 6,200 $0.00 6,200 $20.26
Common Stock Stock Option (Right to Buy) Disposition 2015-11-12 2,325 $0.00 2,325 $30.64
Common Stock Stock Option (Right to Buy) Disposition 2015-11-12 3,900 $0.00 3,900 $48.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-09-21 No 4 M Direct
2,325 2020-09-19 No 4 M Direct
3,900 2021-09-11 No 4 M Direct
Footnotes
  1. These shares were sold in multiple transactions at prices ranging from $67.00- $67.06. The price reported in this column reflects a weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
  2. Fully exercisable.
  3. Options become exercisable in increments of 25% of the total shares granted commencing on the first anniversary of the date of grant.